000 01677 a2200505 4500
005 20250513154518.0
264 0 _c19990114
008 199901s 0 0 eng d
022 _a0954-6928
024 7 _a10.1097/00019501-199809060-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBraga, J C
245 0 0 _aConfirmation that heparin is an alternative means of promoting early reperfusion.
_h[electronic resource]
260 _bCoronary artery disease
_c1998
300 _a335-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAngioplasty, Balloon, Coronary
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHeparin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aMyocardial Reperfusion
_xmethods
650 0 4 _aTime Factors
700 1 _aEsteves, F P
700 1 _aEsteves, J P
700 1 _aLatado, A L
700 1 _aGodinho, A G
700 1 _aAzevedo Júnior, A
700 1 _aBrito, J C
700 1 _aSilva, P R
700 1 _aTeixeira, M S
700 1 _aSouza, V P
700 1 _aRabelo Júnior, A
700 1 _aRocha, M S
773 0 _tCoronary artery disease
_gvol. 9
_gno. 6
_gp. 335-8
856 4 0 _uhttps://doi.org/10.1097/00019501-199809060-00003
_zAvailable from publisher's website
999 _c9776424
_d9776424